Clinical interventions for women with schizophrenia: Pregnancy

Acta Psychiatrica Scandinavica

Volumn 127, Issue 1, 2012, Pages 12-22

  Seeman, M V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ethics; Postpartum; Pregnancy; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; BREAST FEEDING; CHILD PARENT RELATION; CHILDBIRTH; CONTRACEPTION; CUSTODY; HUMAN; MEDLINE; MENTAL HEALTH SERVICE; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; PSYCINFO; PUERPERIUM; SCHIZOPHRENIA; SEXUALITY; SYSTEMATIC REVIEW;

EID: 84871059473     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2012.01897.x     Document Type: Article

References (126)

1. Miller LJ. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull 1997;23:623-635.
2. Kelly DL, Conley RR. Sexuality and schizophrenia: a review. Schizophr Bull 2004;30:767-779.
3. Mccann E. The expression of sexuality in people with psychosis: breaking the taboos. J Adv Nurs 2000;32:132-138.
4. Quinn C, Happell B, Browne G. Talking or avoiding? Mental health nurses' views about discussing sexual health with consumers. Int J Ment Health Nurs 2011;20:21-28.
5. Wright ER, Wright DE, Perry BL, Foote-Ardah CE. Stigma and the sexual isolation of people with serious mental illness. Soc Probl 2007;54:78-98.
6. Perry BL, Wright ER. The sexual partnerships of people with serious mental illness. J Sex Res 2006;43:174-181.
7. Romans S. Sexuality in women with schizophrenia. Curr Womens Health Rev 2010;6:3-11.
8. Matevosyan NR. Reproductive health in women with serious mental illnesses: a review. Sex Disabil 2009;27:109-118.
9. Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev 2005;25:433-457.
10. Nettleman MD, Brewer J, Ayoola A. Why women risk unintended pregnancy. J Fam Pract 2009;58:E1-E5.
11. Meade CS, Sikkema KJ. Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. Commun Ment Health J 2007;43:153-169.
12. Quinn C, Happell B. Getting BETTER: breaking the ice and warming to the inclusion of sexuality in mental health nursing care. Int J Ment Health Nurs 2012;21:154-162.
13. Loeb DF, Lee RS, Binswanger IA, Ellison MC, Aagaard EM. Patient, resident physician, and visit factors associated with documentation of sexual history in the outpatient setting. J Gen Intern Med 2011;26:887-893.
14. Higgins A, Barker P, Begley CM. Sexual health education for people with mental health problems: what can we learn from the literature?J Psychiatr Ment Health Nurs 2006;13:687-697.
15. Southern S, Cade R. Sexuality counseling: a professional specialization comes of age. Fam J 2011;19:246-262.
16. Seeman MV, Ross R. Prescribing contraceptives for women with schizophrenia. J Psychiatr Pract 2011;17:258-269.
17. Akers AY, Gold MA, Borrero S, Santucci A, Schwarz EB. Providers' perspectives on challenges to contraceptive counseling in primary care settings. J Womens Health 2010;19:1163-1170.
18. Haboubi NH, Lincoln N. Views of health professionals on discussing sexual issues with patients. Disabil Rehabil 2003;25:291-296.
19. Seeman MV. Antipsychotic-induced amenorrhea. J Ment Health 2011;20:484-491.
20. Levi A, Dau KQ. Meeting the national health goal to reduce unintended pregnancy. J Obstet Gynecol Neonatal Nurs 2011;40:775-781.
21. Abel K, Rees S. Reproductive and sexual health of women service users: what's the fuss?Adv Psychiatr Treat 2010;16:279-280.
22. Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive methods: a review of the literature. Eur J Contracept Reprod Health Care 2010;15:4-16.
23. Saarikoski S. Chronic illness and contraception. Duodecim 1987;103:593-597.
24. Gabbay V, O'dowd MA, Mamamtavrishvili M, Asnis GM. Clozapine and oral contraceptives: a possible drug interaction. J Clin Psychopharmacol 2002;22:621-622.
25. Kroop LA. Drug interactions with smoking. Am J Health Syst Pharm 2007;64:1917-1921.
26. Cremer M, Masch R. Emergency contraception: past, present and future. Minerva Ginecol 2010;62:361-371.
27. McKee MD, Baquero M, Anderson MR, Alvarez A, Karasz A. Vaginal douching among Latinas: practices and meaning. Matern Child Health J 2009;13:98-106.
28. Klerman LV, Jack BW, Coonrod DV, Lu MC, Fry-Johnson YW, Johnson K. The clinical content of preconception care: care of psychosocial stressors. Am J Obstet Gynecol 2008;199(Suppl 2):S362-S366.
29. Seeman MV. Intervention to prevent child custody loss in mothers with schizophrenia. Schizophr Res Treatment 2012;doi: 10.1155/2012/796763.
30. Frieder A. Preconception counseling for women with schizophrenia. Curr Womens Health Rev 2010;6:12-16.
31. Schubert EW, McNeil TF. Prospective study of adult mental disturbance in offspring of women with psychosis. Arch Gen Psychiatry 2003;60:473-480.
32. Schubert EW, McNeil TF. Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. Am J Psychiatry 2004;161:1030-1037.
33. Schubert EW, McNeil TF. Neuropsychological impairment and its neurological correlates in adult offspring with heightened risk for schizophrenia and affective psychosis. Am J Psychiatry 2005;162:758-766.
34. Schubert EW, McNeil TF. Neurobehavioral deficits in young adult offspring with heightened risk for psychosis who developed schizophrenia-spectrum disorder. Schizophr Res 2007;94:107-113.
35. Dickens BM, Cook RJ. Ethical and legal approaches to 'the fetal patient'. Int J Gynecol Obstet 2003;83:85-91.
36. Árnason V. Gadamerian dialogue in the patient-professional interaction. Med Health Care Philos 2000;3:17-23.
37. Coverdale JH, Mccullough LB, Chervenak FA. Assisted and surrogate decision making for pregnant patients who have schizophrenia. Schizophr Bull 2004;30:659-664.
38. Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology 2011;24:595-607.
39. Shibli-Rahhal A, Schlechte J. Hyperprolactinemia and infertility. Endocrinol Metab Clin North Am 2011;40:837-846.
40. Cookson J, Hodgson R, Wildgust HJ. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis. J Psychopharmacol 2012;26:42-51.
41. Shim JC, Shin JG, Kelly DL et al.Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. Am J Psychiatry 2007;164:1404-1410.
42. Mastroiacovo P, Leoncini E. More folic acid, the five questions: why, who, when, how much, and how. BioFactors 2011;37:272-279.
43. Spielvogel AM, Lee EK. Indication for psychiatric inpatient hospitalization for pregnant psychotic women. Curr Womens Health Rev 2010;6:44-50.
44. Coverdale JH, McCullough LB, Chervenak FA. Ethical issues in managing the pregnancies of patients with schizophrenia. Curr Womens Health Rev 2010;6:63-67.
45. Wehby GL, Prater K, McCarthy AM, Castilla EE, Murray JC. The impact of maternal smoking during pregnancy on early child neurodevelopment. J Hum Cap 2011;5:207-254.
46. Petersen Z, Steyn K, Everett-Murphy K, Emmelin M. Pregnant women's responses to a tailored smoking cessation intervention: turning hopelessness into competence. Global Health Action 2010;3:5379.
47. Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011;106:52-61.
48. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Syst Rev 2009;doi: 10.1002/14651858.CD001055.pub3.
49. American College of Obstetricians and Gynecologists (ACOG) Educational Bulletin. Smoking cessation during pregnancy. Int J Gynaecol Obstet 2001;75:345-348.
50. Havens JR, Simmons LA, Shannon LM, Hansen WF. Factors associated with substance use during pregnancy: results from a national sample. Drug Alcohol Depend 2009;99:89-95.
51. Fergusson DM, Horwood LJ, Northstone K. Maternal use of cannabis and pregnancy outcome. Br J Obstet Gynecol 2002;109:21-27.
52. Mccabe JE, Arndt S. Demographic and substance abuse trends among pregnant and non-pregnant women: eleven years of treatment admission data. Matern Child Health J 2012;16:1696-1702.
53. Moore DG, Turner JJT, Parrott AC et al.During pregnancy, recreational drug-using women stop taking ecstasy (MDMA) and reduce alcohol consumption but continue to smoke tobacco and cannabis. J Psychopharmacol 2010;24:1403-1410.
54. Wu C-S, Jew CP, Lu H-C. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurol 2011;6:459-480.
55. Gray TR, Eiden RD, Leonard KE, Connors GJ, Shisler S, Huestis MA. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem 2010;56:1442-1450.
56. Grant T, Huggins J, Graham JC, Ernst C, Whitney N, Wilson D. Maternal substance abuse and disrupted parenting: distinguishing mothers who keep their children from those who do not. Child Youth Serv Rev 2011;33:2176-2185.
57. Madgula RM, Groshkova T, Mayet S. Illicit drug use in pregnancy: effects and management. Expert Rev Obstet Gynecol 2011;6:179-192.
58. Thornton LK, Baker AL, Johnson MP, Kay-Lambkin F, Lewin TJ. Reasons for substance use among people with psychotic disorders: method triangulation approach. Psychol Addict Behav 2012;37:427-434.
59. Miller LJ. Psychotherapy for pregnant women with schizophrenia. Curr Womens Health Rev 2010;6:39-43.
60. Nace EP, Birkmayer F, Sullivan MA et al.Socially sanctioned coercion mechanisms for addiction treatment. Am J Addiction 2007;16:15-23.
61. Lambert B, Scheiner M, Campbell D. Ethical issues and addiction. J Addict Disord 2010;29:164-174.
62. Sullivan MA, Birkmayer F, Boyarsky BK et al.Uses of coercion in addiction treatment: clinical aspects. Am J Addiction 2008;17:36-47.
63. Urbanoski KA. Coerced addiction treatment: client perspectives and the implications of their neglect. Harm Reduct J 2010;7:13.
64. Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 2010;36:518-544.
65. Newport DJ, Calamaras MR, Devane CL et al.Atypical administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 2007;164:1214-1220.
66. Lin HC, Chen IJ, Chen YH, Lee HC, Wu FJ. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?Schizophr Res 2010;116:55-60.
67. Reis M, Källén BA. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28:279-288.
68. Barnes TR, Schizophrenia Consensus Group of British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2011;25:567-620.
69. Newham JJ, Thomas SH, Macritchie K, Mcelhatton PR, Mcallister-Williams RH. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008;192:333-337.
70. Carmichael SL, Rasmussen SA, Shaw GM. Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol 2010;88:804-810.
71. Stern SJ, Matok I, Kapur B, Koren G. Dosage requirements for periconceptional folic acid supplementation: accounting for BMI and lean body weight. J Obstet Gynaecol Can 2012;34:374-378.
72. Heseker H. Folic acid and other potential measures in the prevention of neural tube defects. Ann Nutr Metab 2011;59:41-45.
73. Galbally M, Snellen M, Lewis AJ. A review of the use of psychotropic medication in pregnancy. Curr Opin Obstet Gynecol 2011;23:408-414.
74. Mccauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J. Antipsychotics in pregnancy. J Psychiatr Ment Health Nurs 2010;17:97-104.
75. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005;162:79-91.
76. Einarson A. Risk/safety of psychotropic medication during pregnancy. Can J Clin Pharmacol 2009;16:e58-e65.
77. Tran L. Legal rights and the maternal-fetal conflict. The Science Creative Q 2005; Available at: http://www.scq.ubc.ca/legal-rights-and-the-maternal-fetal-conflict/
78. Savulescu J. Future people, involuntary medical treatment in pregnancy and the duty of easy rescue. Utilitas 2007;19:1-20.
79. Kaplan M. "A Special Class of Persons": pregnant women's right to refuse medical treatment after Gonzales v. Carhart, 13 U. PA. J. CONST. L. 145, 2010.
80. Chervenak FA, Mccullough LB, Brent RL. The professional responsibility model of obstetrical ethics: avoiding the perils of clashing rights. Am J Obstet Gynecol 2011;205:315.e1-315.e5.
81. Carroli G, Villar J, Piaggio G et al.WHO systematic review of randomized controlled trials of routine antenatal care. Lancet 2001;357:1565-1570.
82. Lin HC, Chen YH, Lee HC. Prenatal care and adverse pregnancy outcomes among women with schizophrenia: a nationwide population-based study in Taiwan. J Clin Psychiatry 2009;70:1297-1303.
83. Raatikainen K, Heiskanen N, Heinonen S. Under-attending free antenatal care is associated with adverse pregnancy outcomes. BMC Public Health 2007;7:268.
84. Zervas IM, Theleritis C, Soldatos CR. Using ECT in schizophrenia: a review from a clinical perspective. World J Biol Psychiatry 2012;13:96-105.
85. Baghai TC, Möller HJ. Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci 2008;10:105-117.
86. Payne NA, Prudic J. Electroconvulsive therapy Part I: a perspective on the evolution and current practice of ECT. J Psychiatr Pract 2009;15:346-368.
87. Shah A, Christopherson R. Prenatal care for women with schizophrenia. Curr Womens Health Rev 2010;6:28-33.
88. Altarac M, Strobino D. Abuse during pregnancy and stress because of abuse during pregnancy and birth weight. J Am Med Women's Assoc 2002;57:208-214.
89. Morgan JF, Zolese G, Mcnulty J, Gebhardt S. Domestic violence among female psychiatric patients: cross-sectional survey. Psychiatrist Online 2010;34:461-464.
90. Lewin LC, Abdrbo A, Burant CJ. Domestic violence in women with serious mental illness involved with child protective services. Issues Ment Health Nurs 2010;31:128-136.
91. Bale TL. Sex differences in prenatal epigenetic programming of stress pathways. Stress 2011;14:348-356.
92. Class QA, Lichenstein P, Långström N, D'onofrio BM. Timing of prenatal maternal exposure to severe life events and adverse pregnancy outcomes: a population study of 2.6 million pregnancies. Psychosom Med 2011;73:234-241.
93. Dunkel Schetter C. Psychological science on pregnancy: stress processes, biopsychosocial models, and emerging research issues. Annu Rev Psychol 2011;62:531-558.
94. Pávek P, Ceckova M, Staud F. Variation of drug kinetics in pregnancy in man. Curr Drug Metab 2009;10:520-529.
95. Tracy TS, Venkataramanan R, Glover DD, Caritis SN, National Institute for Child Health and Human Development Network of Maternal-Fetal-Medicine Units. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol, 2005;192:633-639.
96. Feghali MN, Mattison DR. Clinical therapeutics in pregnancy. J Biomed Biotech 2011;doi: 10.1155/2011/783528.
97. Monostory K, Dvorak Z. Steroid regulation of drug-metabolizing cytochromes P450. Curr Drug Metab 2011;12:154-172.
98. Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf 2007;30:247-264.
99. MGH Center for Women's Mental Health. http://www.womensmentalhealth.org/posts/new-fda-warning-on-the-use-of-antipsychotic-medications-in-pregnancy/. Accessed March 9, 2011.
100. Solari H. Psychotic denial of pregnancy. Curr Womens Health Rev 2010;6:22-27.
101. Spinelli MG. Postpartum psychosis: detection of risk and management. Am J Psychiatry 2009;166:405-408.
102. Nager A, Dundquist K, Ramírez-León V, Johansson LM. Obstetric complications and postpartum psychosis: a follow-up study of 1.1 million first-time mothers between 1975 and 2003 in Sweden. Acta Psychiatr Scand 2008;117:12-19.
103. Sit D, Rothschild AJ, Wisner KL. A review of postpartum psychosis. J Womens Health 2006;15:352-368.
104. Garfield P, Kent A, Paykel ES, Creighton FJ, Jacobson RR. Outcome of postpartum disorders: a 10year follow-up of hospital admissions. Acta Psychiatr Scand 2004;109:434-439.
105. Vigod SN, Ross LE. Epidemiology of psychotic symptoms during pregnancy and postpartum in women with schizophrenia. Curr Womens Health Rev 2010;6:17-21.
106. Ewertzon M, Anderched B, Svensson E, Lützén K. Family members' expectation of the psychiatric healthcare professionals' approach towards them. J Psychiatr Ment Health Nurs 2011;18:146-157.
107. Ewertzon M, Lützén K, Svensson E, Anderched B. Family members' involvement in psychiatric care: experiences of the healthcare professionals' approach and feeling of alienation. J Psychiatr Ment Health Nurs 2010;17:422-432.
108. Wilkinson C, Mcandrew S. 'I'm not an outsider, I'm his mother!' A phenomenological enquiry into carer experiences of exclusion from acute psychiatric settings. Int J Ment Health Nurs 2008;17:392-401.
109. American Pregnancy Association. http://www.americanpregnancy.org/firstyearoflife/breastfeedingandbottle.html. Updated October 2011.
110. U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm. Accessed March 30, 2012.
111. Dayan J, Graignic-Philippe R, Seligmann C, Andro G. Use of antipsychotics and breastfeeding. Curr Womens Health Rev 2011;7:37-45.
112. Gentile S. Infant safety with antipsychotic therapy in breast-feeding: a systematic review. J Clin Psychiatry 2008;69:666-673.
113. Becker A, Mayor GF, Elisabeth JS. Psychotropic medications and breastfeeding. Prim Psychiatr 2009;16:42-51.
114. Frost DO, Cerceo Page S, Carroll C, Kolb B. Early exposure to haloperidol or olanzapine induces long-term alterations of dendritic Form. Synapse 2010;64:191-199.
115. Guillemot J, Laborie C, Dutriez-Casteloot I et al.Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring?Eur J Pharmacol 2011;667:13-16.
116. David DH, Styron T, Davidson L. Supported parenting to meet the needs and concerns of mothers with severe mental illness. Am J Psychiatr Rehabil 2011;14:137-153.
117. Hollingsworth L. Child custody loss among women with persistent severe mental illness. Soc Work Res 2004;28:199-209.
118. Mason C, Subedi S, Davis RB. Clients with mental illness and their children: implications for clinical practice. Issues Ment Health Nurs 2007;28:1105-1123.
119. Darlington Y, Feeney JA, Rixon K. Practice challenges at the intersection of child protection and mental health. Child Fam Soc Work 2005;10:239-247.
120. Kahng SK, Oyserman D, Bybee D, Mowbray C. Mothers with serious mental illness: when symptoms decline does parenting improve?J Fam Psychol 2008;22:162-166.
121. Wan MW, Moulton S, Abel KM. A review of mother-child relational interventions and their usefulness for mothers with schizophrenia. Arch Womens Ment Health 2008;11:171-179.
122. Joy CB, Saylan M. Mother and baby units for schizophrenia. Cochrane Database Syst Rev 2007;24:CD006333.
123. Darlington Y, Feeney JA, Rixona K. Interagency collaboration between child protection and mental health services: practices, attitudes and barriers. Child Abuse Negl 2005;29:1085-1098.
124. Winters NC, Metz WP. The wraparound approach in systems of care. Psychiatr Clin North Am 2009;32:135-151.
125. Cook J, Steigman P. Experiences of parents with mental illnesses and their services needs. J NAMI Calif 2000;11:21-23.
126. Brockington I, Chandra P, Dubowitz H et al.WPA guidance on the protection and promotion of mental health in children of persons with severe mental disorders. World Psychiatry 2011;10:93-102.